INDEPENDENT RESEARCH &
COMMISSION MANAGEMENT
INDEPENDENT RESEARCH & COMMISSION MANAGEMENT
GATEWAY TO INDEPENDENT RESEARCH
• Providing the buy-side with expert advice on the Independent Research landscape and access
to best-of-breed Independent Research Providers (IRPs) and specialist Data Providers
• Unparalleled expertise ~ 20 years’ combined experience
• Holistic solution encompassing all aspects of Independent Research procurement, management,
funding and reporting
COMMISSION MANAGEMENT SOLUTIONS
• Access to market-leading Commission Management and Aggregation platform and high-quality
execution services
• Deep understanding of the FCA’s policy on the use of dealing commission as well as the
overall regulatory environment
CONFLICT-FREE
•
•
•
•
Independent, impartial advice
No economic relationships with IRPs
No traditional research department
Conflicted manager and aggregator of research commissions
November 2014 / Marex Spectron / Independent Research & Commission
Management
2
INDEPENDENT RESEARCH
THE BROKEN SELL-SIDE RESEARCH MODEL
• Conflicts of interest, no exclusivity, a lack of ‘out of the box’ contrarian
thinking, no customisation, and research perceived as ‘free’ through bundled services
ADDING VALUE – A UNIQUE SERVICE
• Introductory Broker
• One of the largest distributors of Independent Research in the UK
• Relationships with a large number of providers globally, covering all asset classes
and investment methodologies
• Due diligence carried out to assess quality of IRPs output
• Optimising ROI on Research Spending
• Anecdotal evidence suggests that the cost of Independent Research is substantially
lower than the implicit cost of research produced by the bulge-bracket; engaging
Marex Spectron to construct a research framework can add real savings to a research
budget
• Pricing & Budgeting
• Access to Marex Spectron IRP Pricing Data
• Curation Services & IRP Management
• Relationship management and associated reporting and administration
November 2014 / Marex Spectron / Independent Research & Commission Management
3
INDEPENDENT RESEARCH
ADDING VALUE – CONSULTING SERVICES
• Deep Dives
• Customised IRP search and recommendations related to specific client queries
• Regular publications/reviews of leading IRPs
• Focusing on emerging investment themes, methodologies & geographies
• Primary Market Research
• Access to organisations that can perform proprietary channel checks, and / or
detailed global, multi-lingual surveys of buyers, customers or suppliers – designed
and co-ordinated in consultation with Marex Spectron
EVENTS
• Regularly host events promoting Independent Research, often in collaboration with IRPs
• Client lunches with prominent speakers
• Regulatory briefings
• Topical presentations and seminars, hosted in conjunction with prominent researchers
• Regular contributor in Financial media including Financial News, Eurohedge and as part of
Integrity Research in the USA
November 2014 / Marex Spectron / Independent Research & Commission
Management
4
COMMISSION MANAGEMENT
MANAGING COMMISSIONS – STATE OF THE ART TOOLS
• Commission Management
• Specialist in Commission Management
• Aggregator of CSA funds for multiple brokers and counterparties
• Segregation of client money
• Online Solution
• In association with a leading vendor, Marex Spectron now offers clients access to a
market-leading Commission Management platform
• Platform is a fully-integrated online portal with the following features:
o Trade Reconciliation - Automated trade-matching algorithm for all broker trade
files
o Invoice Management - Easy uploading of invoices and simple delegation to brokers
for payment
o Commission Management - Full view of each transaction and balances across all
brokers
o Reporting - Complete audit-trail of all transaction data
o Broker Vote - Customisable parameters to support a client’s broker voting process
November 2014 / Marex Spectron / Independent Research & Commission Management
5
RELATED SERVICES
CASH EQUITIES
• Team of professional, highly experienced Sales-Traders working with customer execution
traders
• Considered and thoughtful approach to execution of client orders
• Conflict-free; pure agency-basis
• Broad touch execution with high-touch care orders combined with access to smart orderrouting / algorithmic tools and light and dark liquidity pools
• Trading technology underpinned by Fidessa OMS platform; supplemented by trading and analysis
tools developed in-house to enhance overall quality of execution
• Fully FIX-compatible to receive and update care orders
• Markets traded – UK and all major European markets; South Africa; Poland and Czech; North
America and selected APAC markets
• Settlement is either via self-clearing arrangement with Bank of New York Mellon or a Model B
arrangement provided by Pershing Securities Ltd
November 2014 / Marex Spectron / Independent Research & Commission
Management
6
REGULATORY ENVIRONMENT
PS14/07,
DP14/03, MIFID II AND BEYOND
• Latest summary of regulatory developments provided
• Ongoing observation, analysis and reporting
• Collaboration with regulators, industry experts, researchers and fund management houses
• Marex Spectron well positioned to assist in FCA-compliant processes:
• Independent
• Research impartiality
• Broker neutrality
• Conflict-free
• CSAs promote use of best-execution and transparent reporting of research pricing
November 2014 / Marex Spectron / Independent Research & Commission
Management
7
CONTACT DETAILS
Nicholas Dray
NDray@marexspectron.com
T +44 (0)20 7650 4485
M + 44 7785 948 461
Edward Blad
EBlad@marexspectron.com
T +44 (0)20 7650 4486
M + 44 7795 118 744
London: Head Office
Level Five 155 Bishopsgate
London EC2M 3TQ
marexspectron.com
November 2014 / Marex Spectron / Independent Research & Commission Management
8
THIS PRESENTATION HAS BEEN PREPARED BY MAREX SPECTRON FOR INFORMATION PURPOSES ONLY. MAREX SPECTRON DOES NOT GIVE ANY REPRESENTATION OR WARRANTY, WHETHER EXPRESS OR IMPLIED, AS TO THE
ACCURACY,COMPLETENESS,CURRENCYORFITNESSFORANYPURPOSEORUSEOFANYINFORMATIONINTHISPRESENTATION.
INFORMATIONINTHISPRESENTATIONSHOULDNOTBECONSIDEREDASADVICE,ORASARECOMMENDATIONORSOLICITATIONTOPURCHASEOROTHERWISEDEALINSECURITIES,INVESTMENTSORANYOTHERPRODUCTS. IT
HAS BEEN PREPARED FOR INSTITUTIONAL CLIENTS, IS NOT DIRECTED AT RETAIL CUSTOMERS AND DOES NOT TAKE INTO ACCOUNT PARTICULAR INVESTMENT OBJECTIVES, RISK APPETITES, FINANCIAL SITUATIONS OR NEEDS.
RECIPIENTSOFTHEPRESENTATIONSHOULDMAKETHEIROWNTRADINGORINVESTMENTDECISIONSBASEDUPONTHEIROWNFINANCIALOBJECTIVESANDFINANCIALRESOURCES.
THIS PRESENTATION MAY CONTAIN FORWARD LOOKING STATEMENTS INCLUDING STATEMENTS REGARDING OUR INTENT, BELIEF OR CURRENT EXPECTATIONS WITH RESPECT TO MAREX SPECTRON’S BUSINESSES AND
OPERATIONS, MARKET CONDITIONS, RESULTS OF OPERATION AND FINANCIAL CONDITION, CAPITAL ADEQUACY, SPECIFIC PROVISIONS AND RISK MANAGEMENT PRACTICES. READERS ARE CAUTIONED NOT TO PLACE UNDUE
RELIANCEONTHESEFORWARDLOOKINGSTATEMENTSWHICHMAYBESUBJECTTOCHANGEWITHOUTNOTICE.WHILEREASONABLECAREHASBEENUSEDINTHEPREPARATIONOFFORECASTINFORMATION,ACTUALRESULTS
MAYVARYINAMATERIALLYPOSITIVEORNEGATIVEMANNER.FORECASTSANDHYPOTHETICALEXAMPLESARESUBJECTTOUNCERTAINTYANDCONTINGENCIESOUTSIDEMAREXSPECTRON’SCONTROL.PASTPERFORMANCEIS
NOTARELIABLEINDICATIONOFFUTUREPERFORMANCE.
THE MAREX SPECTRON® GROUP OF COMPANIES INCLUDING MAREX FINANCIAL LIMITED, SPECTRON ENERGY SERVICES LIMITED, MAREX USA LIMITED, MAREX NORTH AMERICA LLC, MAREX HONG KONG LIMITED, MAREX
SPECTRONASIAPTELTDANDSPECTRONENERGY(ASIA)PTELTD(INDIVIDUALLYANDCOLLECTIVELY“MAREXSPECTRON”).
THIS PRESENTATION WAS APPROVED BY MAREX FINANCIAL LIMITED (“MFL”). MFL IS INCORPORATED UNDER THE LAWS OF ENGLAND AND WALES (COMPANY NO. 5613061 AND VAT REGISTRATION NO. GB 872 8106 13), IS
AUTHORISED AND REGULATED BY THE FINANCIAL CONDUCT AUTHORITY (FCA REGISTRATION NUMBER 442767) AND IS A MEMBER OF THE LONDON STOCK EXCHANGE. MFL’S REGISTERED ADDRESS IS AT 155 BISHOPSGATE,
LONDON,EC2M3TQ.
November 2014 / Marex Spectron / Independent Research & Commission
Management
9